Group One Trading
ARCT icon

Group One Trading’s Arcturus Therapeutics ARCT Stock Holding History

Group One Trading’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158K Buy
20,500
+19,500
+1,950% +$142K ﹤0.01% 4313
2025
Q4 		$6.13K Sell
1,000
-51,000
-98% -$551K ﹤0.01% 7081
2025
Q3 		$958K Buy
52,000
+51,100
+5,678% +$821K ﹤0.01% 3078
2025
Q2 		$11.7K Sell
900
-12,900
-93% -$153K ﹤0.01% 6618
2025
Q1 		$146K Buy
+13,800
New +$219K ﹤0.01% 4273
2024
Q2 		– Sell
-7,200
Closed -$243K – 6673
2024
Q1 		$243K Sell
7,200
-25,500
-78% -$904K ﹤0.01% 3384
2023
Q4 		$1.03M Buy
32,700
+2,700
+9% +$64.2K ﹤0.01% 2437
2023
Q3 		$767K Sell
30,000
-21,000
-41% -$647K ﹤0.01% 2524
2023
Q2 		$1.46M Buy
51,000
+1,200
+2% +$32.7K ﹤0.01% 2000
2023
Q1 		$1.19M Buy
49,800
+21,800
+78% +$391K ﹤0.01% 1977
2022
Q4 		$475K Sell
28,000
-36,400
-57% -$635K ﹤0.01% 3093
2022
Q3 		$954K Sell
64,400
-6,400
-9% -$107K ﹤0.01% 2621
2022
Q2 		$1.11M Buy
70,800
+12,800
+22% +$251K ﹤0.01% 2651
2022
Q1 		$1.56M Sell
58,000
-13,100
-18% -$334K ﹤0.01% 2649
2021
Q4 		$2.63M Buy
71,100
+22,000
+45% +$896K ﹤0.01% 2303
2021
Q3 		$2.35M Buy
49,100
+33,200
+209% +$1.49M ﹤0.01% 2486
2021
Q2 		$538K Sell
15,900
-49,300
-76% -$1.67M ﹤0.01% 4146
2021
Q1 		$2.69M Buy
65,200
+100
+0.2% +$5.96K ﹤0.01% 2140
2020
Q4 		$2.82M Buy
65,100
+13,900
+27% +$941K ﹤0.01% 1755
2020
Q3 		$2.2M Sell
51,200
-13,400
-21% -$665K 0.01% 1522
2020
Q2 		$3.02M Buy
64,600
+31,100
+93% +$1.07M 0.01% 1165
2020
Q1 		$455K Sell
33,500
-700
-2% -$8.96K ﹤0.01% 2116
2019
Q4 		$372K Buy
34,200
+11,800
+53% +$124K ﹤0.01% 2672
2019
Q3 		$230K Buy
+22,400
New +$242K ﹤0.01% 2981
2018
Q3 		– Sell
-1,700
Closed -$14K – 5158
2018
Q2 		$14K Buy
+1,700
New +$11K ﹤0.01% 4505
2017
Q2 		– Sell
-3,800
Closed -$30K – 4718
2017
Q1 		$30K Buy
3,800
+586
+18% +$5.42K ﹤0.01% 3685
2016
Q4 		$47K Sell
3,214
-143
-4% -$2.14K ﹤0.01% 3289
2016
Q3 		$58K Buy
3,357
+2,114
+170% +$68.3K ﹤0.01% 3264
2016
Q2 		$39K Sell
1,243
-228
-15% -$7.19K ﹤0.01% 3447
2016
Q1 		$39K Sell
1,471
-1,100
-43% -$37.2K ﹤0.01% 3396
2015
Q4 		$113K Buy
2,571
+971
+61% +$43.7K ﹤0.01% 2904
2015
Q3 		$68K Sell
1,600
-814
-34% -$42.8K ﹤0.01% 3326
2015
Q2 		$111K Sell
2,414
-4,243
-64% -$194K ﹤0.01% 3000
2015
Q1 		$262K Buy
6,657
+1,371
+26% +$60.3K ﹤0.01% 2155
2014
Q4 		$138K Sell
5,286
-9,900
-65% -$315K ﹤0.01% 2594
2014
Q3 		$1.64M Buy
15,186
+14,372
+1,766% +$1.87M 0.03% 805
2014
Q2 		$99K Buy
+814
New +$98.3K ﹤0.01% 2997

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's ARCT Position: Q4 2025 in Review

Group One Trading sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 44,427 shares — an estimated $480K sold.

Group One Trading first reported a position in ARCT in Q4 2014 and held it in 36 quarters. The position peaked at $1.47M in Q4 2015. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Group One Trading reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 44,427 Arcturus Therapeutics shares in Q4 2025, an estimated $480K.
  • Group One Trading first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 36 quarters.
  • Group One Trading's Arcturus Therapeutics position peaked at $1.47M in Q4 2015.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.